Skip to main content
. 2021 Feb 18;59(3):e02880-20. doi: 10.1128/JCM.02880-20

TABLE 1.

Initial and confirmatory LoDs for the Abbott BinaxNOW COVID-19 Ag cardb

Sample Dilution No. of initial replicates detected/no. tested No. of confirmatory replicates detected/no. tested Initial % positive Confirmatory % positive No. of copies/ml (ddPCR) No. of copies/swab (ddPCR) No. of copies/ml (cobas) No. of copies/swab (cobas)
S0a Neat 3/3 100 5.65 × 107 2.83 × 106 1.13 × 108 5.64 × 106
S1 1:10 3/3 100 5.65 × 106 2.83 × 105 1.13 × 107 5.64 × 105
S1-2 1:20 3/3 100 2.83 × 106 1.42 × 105 5.64 × 106 2.82 × 105
S1-4 1:40 3/3 100 1.41 × 106 7.05 × 104 2.82 × 106 1.41 × 105
S1-5 1:50 3/3 100 1.13 × 106 5.65 × 104 2.26 × 106 1.13 × 105
S1-6 1:60 3/3 100 9.42 × 105 4.71 × 104 1.88 × 106 9.40 × 104
S1-7 1:70 3/3 20/20 100 100 8.07 × 105 4.04 × 104 1.61 × 106 8.06 × 104
S1-8 1:80 3/3 17/20 67 85 7.06 × 105 3.53 × 104 1.41 × 106 7.05 × 104
S2 1:100 0/3 0 5.65 × 105 2.83 × 104 1.13 × 106 5.64 × 104
S3 1:1,000 0/3 0 5.65 × 104 2.83 × 103 1.13 × 105 5.64 × 103
Positive control Neat 1/1 1/1 100 100 NA NA NA NA
Negative control Neat 0/1 0/1 0 0 NA NA NA NA
a

S0, the undiluted positive pool, was determined to have a CT of 17.3 for both targets on the Roche cobas 6800 platform.

b

The positive control was a kit-provided swab by Abbott; the negative control was a clinical nasopharyngeal swab previously determined to be negative by Hologic Panther Fusion. Abbreviations: ddPCR, droplet digital PCR; Pos, positive; Neg, negative; NA, not applicable. The two dilutions that confirm the LoD are in boldface.